197 related articles for article (PubMed ID: 18290372)
1. [Morphological changes and prion accumulation in the cerebellar cortex in Creutzfeldt-Jacob disease].
Karmysheva VIa; Gulevskaia TS; Pogodina VV
Arkh Patol; 2007; 69(6):10-5. PubMed ID: 18290372
[TBL] [Abstract][Full Text] [Related]
2. [Prionic neuroinvasion and cerebellar lesion in Creutzfeldt-Jakob disease].
Karmysheva VIa; Pogodina VV
Arkh Patol; 2006; 68(4):27-32. PubMed ID: 16986493
[TBL] [Abstract][Full Text] [Related]
3. [PRP(CJD) reproduction in the cerebral vascular plexus epitheliocytes in a new type of Creutzfeldt-Jakob disease].
Karmysheva VIa; Pogodina VV
Arkh Patol; 2007; 69(5):28-31. PubMed ID: 18074816
[TBL] [Abstract][Full Text] [Related]
4. Loss of cerebellar granule neurons is associated with punctate but not with large focal deposits of prion protein in Creutzfeldt-Jakob disease.
Faucheux BA; Privat N; Brandel JP; Sazdovitch V; Laplanche JL; Maurage CA; Hauw JJ; Haïk S
J Neuropathol Exp Neurol; 2009 Aug; 68(8):892-901. PubMed ID: 19606064
[TBL] [Abstract][Full Text] [Related]
5. Quantification of surviving cerebellar granule neurones and abnormal prion protein (PrPSc) deposition in sporadic Creutzfeldt-Jakob disease supports a pathogenic role for small PrPSc deposits common to the various molecular subtypes.
Faucheux BA; Morain E; Diouron V; Brandel JP; Salomon D; Sazdovitch V; Privat N; Laplanche JL; Hauw JJ; Haïk S
Neuropathol Appl Neurobiol; 2011 Aug; 37(5):500-12. PubMed ID: 21450052
[TBL] [Abstract][Full Text] [Related]
6. Polymorphism at codon 129 of the prion protein gene determines cerebellar pathology in Creutzfeldt-Jakob disease.
Schulz-Schaeffer WJ; Giese A; Windl O; Kretzschmar HA
Clin Neuropathol; 1996; 15(6):353-7. PubMed ID: 8937783
[TBL] [Abstract][Full Text] [Related]
7. Spatial patterns of the pathological changes in the cerebellar cortex in sporadic Creutzfeldt-Jakob disease (sCJD).
Armstrong RA; Cairns NJ
Folia Neuropathol; 2003; 41(4):183-9. PubMed ID: 14977247
[TBL] [Abstract][Full Text] [Related]
8. Distinctive cerebellar immunoreactivity for the prion protein in familial (E200K) Creutzfeldt-Jakob disease.
Jarius C; Kovacs GG; Belay G; Hainfellner JA; Mitrova E; Budka H
Acta Neuropathol; 2003 May; 105(5):449-54. PubMed ID: 12677444
[TBL] [Abstract][Full Text] [Related]
9. Prion protein deposition and abnormal synaptic protein expression in the cerebellum in Creutzfeldt-Jakob disease.
Ferrer I; Puig B; Blanco R; Martí E
Neuroscience; 2000; 97(4):715-26. PubMed ID: 10842016
[TBL] [Abstract][Full Text] [Related]
10. Nestin immunoreactivity of Purkinje cells in Creutzfeldt-Jakob disease.
Mizuno Y; Ohama E; Hirato J; Nakazato Y; Takahashi H; Takatama M; Takeuchi T; Okamoto K
J Neurol Sci; 2006 Jul; 246(1-2):131-7. PubMed ID: 16616189
[TBL] [Abstract][Full Text] [Related]
11. Variant Creutzfeldt-Jakob disease: immunocytochemical studies and image analysis.
Nailon WH; Ironside JW
Microsc Res Tech; 2000 Jul; 50(1):2-9. PubMed ID: 10871542
[TBL] [Abstract][Full Text] [Related]
12. Synaptic pathology and cell death in the cerebellum in Creutzfeldt-Jakob disease.
Ferrer I
Cerebellum; 2002 Jul; 1(3):213-22. PubMed ID: 12879983
[TBL] [Abstract][Full Text] [Related]
13. Clusterin solubility and aggregation in Creutzfeldt-Jakob disease.
Freixes M; Puig B; Rodríguez A; Torrejón-Escribano B; Blanco R; Ferrer I
Acta Neuropathol; 2004 Oct; 108(4):295-301. PubMed ID: 15235804
[TBL] [Abstract][Full Text] [Related]
14. Pathologic prion protein spreading in the peripheral nervous system of a patient with sporadic Creutzfeldt-Jakob disease.
Favereaux A; Quadrio I; Vital C; Perret-Liaudet A; Anne O; Laplanche JL; Petry KG; Vital A
Arch Neurol; 2004 May; 61(5):747-50. PubMed ID: 15148153
[TBL] [Abstract][Full Text] [Related]
15. Curcumin binds to the alpha-helical intermediate and to the amyloid form of prion protein - a new mechanism for the inhibition of PrP(Sc) accumulation.
Hafner-Bratkovic I; Gaspersic J; Smid LM; Bresjanac M; Jerala R
J Neurochem; 2008 Mar; 104(6):1553-64. PubMed ID: 17996023
[TBL] [Abstract][Full Text] [Related]
16. Neuropathological study of cerebellar degeneration in prion disease.
Yang Q; Hashizume Y; Yoshida M; Wang Y
Neuropathology; 1999 Jan; 19(1):33-9. PubMed ID: 19519645
[TBL] [Abstract][Full Text] [Related]
17. Alpha-synuclein-immunoreactive deposits in human and animal prion diseases.
Haïk S; Privat N; Adjou KT; Sazdovitch V; Dormont D; Duyckaerts C; Hauw JJ
Acta Neuropathol; 2002 May; 103(5):516-20. PubMed ID: 11935269
[TBL] [Abstract][Full Text] [Related]
18. Classification of sporadic Creutzfeldt-Jakob disease revisited.
Cali I; Castellani R; Yuan J; Al-Shekhlee A; Cohen ML; Xiao X; Moleres FJ; Parchi P; Zou WQ; Gambetti P
Brain; 2006 Sep; 129(Pt 9):2266-77. PubMed ID: 16923954
[TBL] [Abstract][Full Text] [Related]
19. Extraneural pathologic prion protein in sporadic Creutzfeldt-Jakob disease.
Glatzel M; Abela E; Maissen M; Aguzzi A
N Engl J Med; 2003 Nov; 349(19):1812-20. PubMed ID: 14602879
[TBL] [Abstract][Full Text] [Related]
20. Early destruction of the extracellular matrix around parvalbumin-immunoreactive interneurons in Creutzfeldt-Jakob disease.
Belichenko PV; Miklossy J; Belser B; Budka H; Celio MR
Neurobiol Dis; 1999 Aug; 6(4):269-79. PubMed ID: 10448054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
